Crosslinked polyorganosiloxane and personal care composition containing same
A crosslinked polyorganosiloxane is obtained from the free radical-initiated addition polymerization of polymerizable polyorganosiloxane containing at least two free radical polymerizable groups.
1. A personal care composition comprising at least one O/W gel emulsion of crosslinked polyorganosiloxane which comprises at least one member selected from the group consisting of (a) crosslinked polyorganosiloxane O/W gel emulsion obtained from the free radical-initiated addition polymerization under emulsion polymerization reactions conditions of polyorganosiloxane I containing ≥2 free radical polymerizable groups and 0 or ≥1 hydrosilyl group(s) and, optionally, polyorganosiloxane II containing 0 or 1 free radical polymerizable group and ≥1 hydrosilyl group(s), (b) crosslinked polyorganosiloxane O/W gel emulsion (a) which is substantially devoid of precious metal, (c) concentrate of crosslinked polyorganosiloxane (a), and (d) concentrate of crosslinked polyorganosiloxane O/W gel emulsion (b), and wherein polyorganosiloxane I consists of the general formula I:
M a M H b M V c M″ d M* e D f D H g D V h D″ i D* j T k T H l T V m T″ n T* o Q p I
wherein
M=R 1 R 2 R 3 SiO 1/2 ;
M H =R 4 R 5 HSiO 1/2 ;
M V =R 6 R 7 R 8 SiO 1/2 ;
M″=R 9 R 10 R 22 SiO 1/2 ;
M*=R 11 R 12 R 23 SiO 1/2 ;
D=R 13 R 14 SiO 2/2
D H =R 15 HSiO 2/2 ;
D V =R 16 R 17 SiO 2/2 ;
D″=R 18 R 22 SiO 2/2 ;
D*=R 19 R 23 SiO 2/2 ;
T=R 20 SiO 3/2 ;
T H =HSiO 3/2 ;
T V =R 21 Sio 3/2 ;
T″=R 22 SiO 3/2 ;
T*=R 23 SiO 3/2 ; and,
Q=SiO 4/2
in which R 1 , R 2 , R 3 , R 4 , R 5 , R 7 , R 8 , R 13 , R 14 , R 15 , R 17 and R 20 each independently is a monovalent hydrocarbon group of up to 60 carbon atoms; R 6 , R 16 and R 21 each independently is a free radical polymerizable group; R 9 , R 10 and R 18 each independently is a monovalent hydrocarbon group of up to 60 carbon atoms or R 22 ; each R 22 independently is a monovalent alkoxy group of up to 60 carbon atoms; R 11 , R 12 and R 19 each independently is a monovalent hydrocarbon group of up to 60 carbon atoms, or R 23 ; each R 23 independently is a divalent alkylene group R 24 of from 3 to 6 carbon atoms to which is bonded one or more alkyleneoxy groups having a total of from 2 to 200 carbon atoms containing one or more ether moieties; and, subscripts a, b, c, d, e, f, g, h, i, j, k, l, m, n, o and p each independently is 0 or a positive number subject to the provision that c+h+m≥2; and,
polyorganosiloxane II is defined the same as for polyorganosiloxane I but with the limitation in polyorganosiloxane II that c+h+m is 0 or 1 and b+g+l≥1, and subject to this limitation, each of groups R 1 -R 24 and subscripts a-p of polyorganosiloxane II are selected independently of groups R 1 -R 24 and subscripts a-p of polyorganosiloxane I.
2. The personal care composition of claim 1 wherein at least one of free radical polymerizable groups R 6 , R 16 and R 21 of polyorganosiloxane I is selected from the group consisting of:
in which each R 25 independently is a divalent hydrocarbon group of up to 20 carbon atoms, optionally containing one or more heteroatoms; R 26 and R 27 each independently is an ethylenically unsaturated free radical polymerizable group; R 28 is a trivalent hydrocarbon group of up to 20 carbon atoms, optionally containing one or more heteroatoms; and, subscripts q, r and s each independently is 0 or a positive number subject to the limitation that q+r+s≥1.
3. The personal care composition of claim 2 wherein at least one of R 26 and R 27 of polyorganosiloxane I and/or polyorganosiloxane II is selected to be:
in which Y is absent or is an R 25 group as previously defined and R 29 , R 30 and R 31 each independently is hydrogen or a monovalent hydrocarbon group of up to 20 carbon atoms.
4. The personal care composition of claim 1 wherein polyorganosiloxane I is at least one member selected from the group consisting of:
M V c D f D V h M 2-c I(e)
wherein M V , D, D V and M are as previously defined and subscripts c, f and h are 0 or a positive number subject to the limitation that f is 0 to 2000, h is 0 to 500, c is 0 to 2 and c+h is 2 to 500;
M V c D f D V h M 2-c I(f)
wherein M V , D, D V and M are as previously defined and subscripts c, f and h are 0 or a positive number subject to the limitation that f is 0 to 2000, h is 0 to 500, c is 0 to 50 and c +h is 2 to 500;
M V c Q p I(g)
wherein M V , and Q are as previously defined and subscripts c and p are 0 or a positive number subject to the limitation that c is ≥1, p is ≥1 and c+p is 2 to 100; and,
M H b M c V D f D g H D h V M 2-b I(h)
wherein M H , M V , D, D H , D V and M are as defined and b, c, f, g and h are 0 or a positive number subject to the limitation that f is 1 to 1000, b is 0 or 1, c is 0 to 2, b+g is 1 and c+h is 2 to 500; and,
D f D V h I(i)
wherein D and D V are as previously defined and subscripts f and h are 0 or a positive number subject to the limitation that f+h is 3 to 8.
5. The personal care composition of claim 4 wherein:
in polyorganosiloxane I(e), f is 10 to 1000, h is 0 to 100, c+h is 2 to 100 and each M V and D V moiety independently contains a vinyl, allyl, methallyl, acrylate and/or alkacrylate group;
in polyorganosiloxane I(f), f is 10 to 1000, h is 0 to 100, c is 0 to 50, c+h is 2 to 100 and each M V and D V moiety independently contains a vinyl, allyl, methallyl, acrylate and/or alkacrylate group;
in polyorganosiloxane I(g), c is ≥2, p is ≥2, and c+p is 4 to 40 and each M V and D V moiety independently contains a vinyl, methallyl, acrylate and/or alkacrylate group;
in polyorganosiloxane I(h), f is 10 to 300, c+h is 2 to 100 and each M V and D V moiety independently contains a vinyl, allyl, methallyl, acrylate and/or alkacrylate group; and,
in polyorganosiloxane I(i), f+h is 3 to 6 and each D V moiety independently contains a vinyl, allyl, methallyl, acrylate and/or alkacrylate group.
6. The personal care composition of claim 4 wherein:
in polyorganosiloxane I(e), f is 10 to 500 , h is 0 to 50, c+h is 2 to 10 and each M V and D V moiety contains a vinyl group;
in polyorganosiloxane I(f), f is 10 to 500 and c+h is 2 to 50 and each M V and D V moiety contains a vinyl group;
in polyorganosiloxane I(g), c is 3, p is ≥3, and c+p is 6 to 20 and each M V moiety contains a vinyl group;
in polyorganosiloxane I(h), f is 10 to 100, c+h is 2 to 50 and each M V and D V moiety contains a vinyl group; and,
in polyorganosiloxane I(i), f+h is 3 to 5 and each D V moiety contains a vinyl group.
7. The personal care composition of claim 1 wherein polyorganosiloxane II is at least one member selected from the group consisting of:
M H b D f D H g M 2-b II(a)
wherein M H , D, D H and M′ are as previously defined and b, f and g are 0 or a positive number subject to the limitation that f is 10 to 300, g is 0 to 50, b is 0 to 2 and b+g is 1 to 100;
M H b D f D H g D* j M 2-b II(b)
wherein M H , D, D*, D H and M are as previously defined and subscripts b, f, g and j are zero or a positive number subject to the limitation that b is 0 to 2, g is from 0 to 50, j is 0.1 to 10, f is 0 to 500, and b+g is 1 to 100;
M H b Q p M 2-b II(c)
wherein M H , Q and M are as previously defined and b and p are 0 or a positive number subject to the limitation that b is ≥1, p is ≥1 and b+p is 2 to 40; and,
M H b D f D″ i D H g M 2-b II(d)
wherein M H , D, D″, D H and M are as previously defined and b f, I and g are 0 or a positive number subject to the limitations that f is 10 to 50, i is 0 to 20 and b+g is 1 to 100;
M H b M V c D f D H g D V h M 2-b II(e)
wherein M H , M V , D, D H and M are as previously defined and b, c, f, g and h are 0 or a positive number subject to the limitation that f is 1 to 300, b+g is ≥1 and c+h is 1 to 100; and,
D f D H g D V h II(f)
wherein D, D H and D V are as previously defined and f, g and h are 0 or a positive number subject to the limitation that f+g+h is 3 to 7.
8. The personal care composition of claim 7 wherein:
in polyorganosiloxane II(a), f is 10 to 30, g is 1 to 30 and b+g is 1 to 32;
in polyorganosiloxane II(b), g is 1 to 30, j is 0.1 to 8, f is 10 to 150 and b+g is 1 to 32;
in polyorganosiloxane II(c), b is ≥3, p is ≥3, and b+p is 6 to 20;
in polyorganosiloxane II(d), f is 10 to 40, i is 1 to 8 and b+g is 1 to 14;
in polyorganosiloxane II(e), f is 10 to 30, b+g is ≥2 and c+h is 0 or 1; and,
in polyorganosiloxane II(f), f+g+h is 3 to 6.
9. The personal care composition of claim 7 wherein:
in polyorganosiloxane II(a), f is 10 to 25 , g is 2 to 10 and b+g is 2 to 12;
in polyorganosiloxane II(b), g is 2 to 10, j s 0.1 to 6 and f is 10 to 125; and b+g is 2 to 20;
in polyorganosiloxane II(c), b is ≥3, p is ≥3 and b+p is 6 to 18;
in polyorganosiloxane II(d), f is 10 to 35 and b+g is 1 to 10;
in polyorganosiloxane II(e), f is 10 to 24 and b+g ≥3; and,
in polyorganosiloxane II(f)f+g+h is 3 to 5 and D V where present contains a vinyl group.
10. The personal care composition of claim 1 selected from the group consisting of deodorants, antiperspirants, antiperspirant/deodorants, stick and roll-on preparations, skin lotions, moisturizers, toners, cleansing preparations, styling gels, hair dyes, hair color preparations, hair straighteners, nail polish, nail polish remover, sunscreens, anti-aging preparations, lipsticks, lip balms, lip glosses, foundations, face powders, eye liners, eye shadows, blushes, makeup, beauty balms, mascaras, moisturizing preparations, foundations, concealers, body and hand preparations, skin care preparations, face and neck preparations, fragrance preparations, soft focus preparations, night and day skin care preparations, tanning preparations, hand liquids, non-woven preparations for personal care, facial tissue, baby lotions, facial cleansing preparations hair cuticle coats, gels, foam baths, body washes, scrubbing cleansers, controlled-release personal care preparations, hair shampoos, hair conditioners, hair sprays, skin care moisturizing mists, skin wipes, pore skin wipes, pore cleaners, blemish reducers, skin exfoliators, skin desquamation enhancers, anti-acne preparations, skin towelettes, skin cloths, depilatory preparations, personal care lubricants, nail coloring preparations and drug delivery systems for topically applied therapeutics and medicinals.
11. A soft-focus effect composition comprising the personal care composition of claim 1 and at least one other soft-focus effect additive.
12. A soft focus composition exhibiting a soft-focus effect comprising a soft-focus effect-imparting amount of the soft-focus effect composition of claim 11 .
13. The personal care composition of claim 1 wherein at least one of (a)-(d) is produced by a process which employs a free radical initiator and wherein the a free radical initiator is selected from the group consisting of azo initiators, inorganic peroxides, organic peroxides, and redox initiators.
14. The personal care composition of claim 1 , wherein the subscripts a, b, d and e are zero.